Endo Designated Activity Company, a designated activity company limited by shares incorporated under the laws of Ireland (“Endo DAC”), Endo Finance LLC, a Delaware limited liability company, and Endo Finco Inc., a Delaware corporation, both wholly-owned subsidiaries of Endo DAC, formed as special purpose finance vehicles (together, the “Endo Finance Issuers”, and collectively with Endo DAC, the “Issuers”) have issued $1,200,000,000 principal amount of their 6.00 % senior notes due February 2025 (the “Notes”) namely;

(i) $1,196,416,000 principal amount originally issued pursuant to Rule 144A under the United States Securities Act (CUSIP: 29273E AA6; ISIN:US29273EAA64);

and

(ii) $3,584,000 principal amount originally issued pursuant to Regulation S under the United States Securities Act (CUSIP: G3040E AA6; ISIN:USG3040EAA67).